{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:10:06Z","timestamp":1774062606300,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.neulet.2019.134677","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T12:37:18Z","timestamp":1575549438000},"page":"134677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["MDGA1-deficiency attenuates prepulse inhibition with alterations of dopamine and serotonin metabolism: An ex vivo HPLC-ECD analysis"],"prefix":"10.1016","volume":"716","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1511-505X","authenticated-orcid":false,"given":"Md Razib","family":"Hossain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2275-3797","authenticated-orcid":false,"given":"Mostofa","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Tanoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Ojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuba M.","family":"Ansary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4828-1249","authenticated-orcid":false,"given":"Yasushi","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2019.134677_bib0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1017\/S1092852900001358","article-title":"Role of norepinephrine in the pathophysiology of neuropsychiatric disorders","volume":"6","author":"Ressler","year":"2001","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neulet.2019.134677_bib0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neulet.2019.134677_bib0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1073858411401413","article-title":"Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging","volume":"18","author":"Ko","year":"2012","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neulet.2019.134677_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00002512-199812010-00006","article-title":"Depression in Parkinson\u2019s disease: pharmacological characteristics and treatment","volume":"12","author":"Tom","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neulet.2019.134677_bib0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III--the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2019.134677_bib0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0079-6123(08)00906-0","article-title":"Alterations of dopamine and serotonin transmission in schizophrenia","volume":"172","author":"Remington","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neulet.2019.134677_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12402-010-0019-x","article-title":"Animal models of attention deficit\/hyperactivity disorder (ADHD): a critical review","volume":"2","author":"Sontag","year":"2010","journal-title":"Atten. Defic. Hyperact. Disord."},{"key":"10.1016\/j.neulet.2019.134677_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068007","article-title":"Determination of serotonin and dopamine metabolites in human brain microdialysis and cerebrospinal fluid samples by UPLC-MS\/MS: discovery of intact glucuronide and sulfate conjugates","volume":"8","author":"Suominen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2019.134677_bib0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nbd.2017.06.007","article-title":"Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models","volume":"105","author":"Dekker","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2019.134677_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0197-4580(82)90057-4","article-title":"Changes in monoamines and their metabolite levels in some brain regions of aged rats","volume":"3","author":"Ponzio","year":"1982","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2019.134677_bib0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1248\/bpb.b12-00689","article-title":"Simultaneous measurement of serotonin, dopamine and their metabolites in mouse brain extracts by high-performance liquid chromatography with mass spectrometry following derivatization with ethyl chloroformate","volume":"36","author":"Park","year":"2013","journal-title":"Biol. Pharm. Bull."},{"issue":"51 Suppl","key":"10.1016\/j.neulet.2019.134677_bib0060","first-page":"42","article-title":"CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence","author":"Brown","year":"1990","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neulet.2019.134677_bib0065","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/978-1-4684-3860-4_41","article-title":"Studies of CSF 5-HIAA in depression and suicidal behaviour","volume":"133","author":"Asberg","year":"1981","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neulet.2019.134677_bib0070","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00702-017-1746-3","article-title":"Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls","volume":"124","author":"P\u00e5lsson","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"99 Suppl","key":"10.1016\/j.neulet.2019.134677_bib0075","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1007\/BF00442554","article-title":"Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia","author":"Meltzer","year":"1989","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2019.134677_bib0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0074-7742(06)78005-9","article-title":"Alterations of serotonin transmission in schizophrenia","volume":"78","author":"Abi-Dargham","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neulet.2019.134677_bib0085","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mp.2017.16","article-title":"The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment","volume":"22","author":"Ashok","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2019.134677_bib0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2006.05.030","article-title":"MDGA1, an IgSF molecule containing a MAM domain, heterophilically associates with axon- and muscle-associated binding partners through distinct structural domains","volume":"1101","author":"Fujimura","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2019.134677_bib0095","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/cercor\/bhl064","article-title":"Novel IgCAM, MDGA1, expressed in unique cortical area- and layer-specific patterns and transiently by distinct forebrain populations of Cajal-Retzius neurons","volume":"17","author":"Takeuchi","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neulet.2019.134677_bib0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1073\/pnas.1219987110","article-title":"MDGAs interact selectively with neuroligin-2 but not other neuroligins to regulate inhibitory synapse development","volume":"110","author":"Lee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2019.134677_bib0105","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1016\/j.celrep.2017.11.109","article-title":"Loss of synapse repressor MDGA1 enhances perisomatic inhibition, confers resistance to network excitation, and impairs cognitive function","volume":"21","author":"Connor","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.neulet.2019.134677_bib0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.mcn.2003.10.016","article-title":"Identification and characterization of two novel brain-derived immunoglobulin superfamily members with a unique structural organization","volume":"25","author":"Litwack","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neulet.2019.134677_bib0115","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1523\/JNEUROSCI.4935-05.2006","article-title":"Radial migration of superficial layer cortical neurons controlled by novel Ig cell adhesion molecule MDGA1","volume":"26","author":"Takeuchi","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134677_bib0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12307-010-0055-2","article-title":"Expression of human MDGA1 increases cell motility and cell-cell adhesion and reduces adhesion to extracellular matrix proteins in MDCK cells","volume":"4","author":"D\u00edaz-L\u00f3pez","year":"2010","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.neulet.2019.134677_bib0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/dvdy.22496","article-title":"IgSF molecule MDGA1 is involved in radial migration and positioning of a subset of cortical upper-layer neurons","volume":"240","author":"Ishikawa","year":"2011","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.neulet.2019.134677_bib0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1083\/jcb.201206028","article-title":"Interaction between autism-linked MDGAs and neuroligins suppresses inhibitory synapse development","volume":"200","author":"Pettem","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neulet.2019.134677_bib0135","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neuron.2016.08.016","article-title":"Altered cortical dynamics and cognitive function upon haploinsufficiency of the autism-linked excitatory synaptic suppressor MDGA2","volume":"91","author":"Connor","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.134677_bib0140","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/ajmg.b.30726","article-title":"Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene","volume":"147B","author":"K\u00e4hler","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neulet.2019.134677_bib0145","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.schres.2010.11.002","article-title":"The MDGA1 gene confers risk to schizophrenia and bipolar disorder","volume":"125","author":"Li","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2019.134677_bib0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neures.2008.08.006","article-title":"Impaired prepulse inhibition and habituation of acoustic startle response in Japanese patients with schizophrenia","volume":"62","author":"Takahashi","year":"2008","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neulet.2019.134677_bib0155","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0006-3223(99)00148-1","article-title":"Impaired prepulse inhibition of acoustic startle in schizophrenia","volume":"47","author":"Parwani","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2019.134677_bib0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2019.134677_bib0165","doi-asserted-by":"crossref","first-page":"R764","DOI":"10.1016\/j.cub.2013.05.041","article-title":"Interplay of hippocampus and prefrontal cortex in memory","volume":"23","author":"Preston","year":"2013","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neulet.2019.134677_bib0170","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1523\/JNEUROSCI.0840-16.2016","article-title":"Contributions of hippocampus and striatum to memory-guided behavior depend on past experience","volume":"36","author":"Ferbinteanu","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134677_bib0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00213-005-2210-x","article-title":"Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia","volume":"179","author":"Lipina","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2019.134677_bib0180","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/sj.npp.1301072","article-title":"Baseline neurocognitive deficits in the CATIE schizophrenia trial","volume":"31","author":"Keefe","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2019.134677_bib0185","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fnbeh.2016.00202","article-title":"Reduced prepulse inhibition as a biomarker of schizophrenia","volume":"10","author":"Mena","year":"2016","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neulet.2019.134677_bib0190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2019.134677_bib0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","article-title":"Dopamine receptors and the dopamine hypothesis of schizophrenia","volume":"1","author":"Seeman","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.neulet.2019.134677_bib0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41398-017-0071-9","article-title":"Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience","volume":"8","author":"Kesby","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neulet.2019.134677_bib0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0893-133X(87)90006-6","article-title":"Structural brain pathology in schizophrenia revisited: prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid","volume":"1","author":"Doran","year":"1987","journal-title":"Neuropsychopharmacolgy"},{"key":"10.1016\/j.neulet.2019.134677_bib0210","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1176\/ajp.148.2.240","article-title":"Characteristics of psychotic inpatients with high or low HVA levels at admission","volume":"148","author":"Bowers","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2019.134677_bib0215","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.addr.2008.06.002","article-title":"Monoamine oxidase inactivation: from pathophysiology to therapeutics","volume":"60","author":"Bortolato","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neulet.2019.134677_bib0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01271296","article-title":"Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism","volume":"104","author":"Brannan","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neulet.2019.134677_bib0225","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0773.1999.tb02014.x","article-title":"Microdialysis studies on the action of tolcapone on pharmacologically-elevated extracellular dopamine levels in conscious rats","volume":"85","author":"Huotari","year":"1999","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.neulet.2019.134677_bib0230","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1177\/0269881112454228","article-title":"Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition","volume":"26","author":"Laatikainen","year":"2012","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.neulet.2019.134677_bib0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0021-5198(19)39985-8","article-title":"Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359","volume":"55","author":"Kumagae","year":"1991","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neulet.2019.134677_bib0240","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.mp.4000904","article-title":"Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex","volume":"6","author":"Devoto","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2019.134677_bib0245","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1098\/rstb.2012.0109","article-title":"The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse","volume":"367","author":"Jacobsen","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond., B, Biol. Sci."},{"key":"10.1016\/j.neulet.2019.134677_bib0250","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fnbeh.2014.00199","article-title":"Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression","volume":"8","author":"Albert","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neulet.2019.134677_bib0255","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fnbeh.2014.00325","article-title":"Abnormal anxiety- and depression-like behaviors in mice lacking both central serotonergic neurons and pancreatic islet cells","volume":"8","author":"Jia","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neulet.2019.134677_bib0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archpsyc.1990.01810170019003","article-title":"Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents","volume":"47","author":"Kruesi","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2019.134677_bib0265","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0018-506X(03)00132-6","article-title":"Cerebrospinal fluid monoamine and metabolite concentrations and aggression in rats","volume":"44","author":"van der Vegt","year":"2003","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neulet.2019.134677_bib0270","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00213-008-1269-6","article-title":"Social instigation and aggressive behavior in mice: role of 5-HT1A and 5-HT1B receptors in the prefrontal cortex","volume":"201","author":"Centenaro","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2019.134677_bib0275","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1176\/ajp.151.10.1485","article-title":"Low CSF 5-HIAA concentrations and severe aggression and impaired impulse control in nonhuman primates","volume":"151","author":"Mehlman","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2019.134677_bib0280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0364-7722(78)90069-3","article-title":"Monoamine oxidase activity and serotoninergic turnover in human brain","volume":"2","author":"Adolfsson","year":"1978","journal-title":"Prog. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2019.134677_bib0285","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/tpj.2012.35","article-title":"Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humans","volume":"13","author":"Fox","year":"2013","journal-title":"Pharmacogenomics J."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019307803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019307803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:30:03Z","timestamp":1759609803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019307803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":57,"alternative-id":["S0304394019307803"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134677","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MDGA1-deficiency attenuates prepulse inhibition with alterations of dopamine and serotonin metabolism: An ex vivo HPLC-ECD analysis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"134677"}}